Research
Stifel Nicolaus Initiates Coverage on Immunic With Buy Rating, $2.50 Price Target
Immunic (IMUX) has an average rating of Buy and mean price target of $4.94, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)
$IMUX
